Physician
Northwest Arkansas Pathology Associates PA
Northwest Arkansas Pathology Associates PA was paid $2.01M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 33% of everything it billed.
33Billing provider infoNORTHWEST ARKANSAS PATHOLOGY ASSOCIATES PA
FAYETTEVILLE, AR 72703
FAYETTEVILLE, AR 72703
33aNPI1306819263assigned 02/10/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.01M
24GClaims43,106
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Arkansas
Rank by total paid#1 of 26
Median peer was paid$24K
This provider vs. median84×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,447 | $189K | |
| 2019 | 4,932 | $185K | |
| 2020 | 7,549 | $342K | |
| 2021 | 11,017 | $506K | |
| 2022 | 6,134 | $273K | |
| 2023 | 5,225 | $285K | |
| 2024incomplete | 3,802 | $230K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 33% | 11,283 | 10,074 | $664K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 28% | 5,815 | 5,427 | $553K |
| 88307 | 14% | 2,908 | 2,648 | $276K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.7% | 2,473 | 2,253 | $94K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.7% | 2,477 | 2,255 | $94K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4.6% | 2,916 | 2,686 | $92K |
| 88304 | 3.8% | 2,855 | 2,533 | $77K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.7% | 5,042 | 4,720 | $74K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 625 | 489 | $24K |
| 88342 | <1% | 466 | 393 | $18K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 403 | 348 | $14K |
| 88142 | <1% | 1,346 | 1,123 | $14K |
5 more codes
| 88341 | <1% | 104 | $12K | |
| 88302 | <1% | 14 | $691.86 | |
| 88141 | <1% | 211 | $629.14 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,976 | $475.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 192 | $21.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUI, ANTHONY (MEDICAL DIRECTOR)